Orexo has long experience in successful collaborations, which has enabled the development and launch of novel products, offering improved treatment options for patients worldwide. Image below: Our colleagues Petter Wereen and "Boz" Coburn attending the Bio International Convention, where they were talking to pharma companies and other industry professionals with a focus on our scalable drug delivery technology AmorphOX and the therapies that are in our pipeline. #drugdevelopment #OX640 #largemolecules
Orexo AB publ’s Post
More Relevant Posts
-
Will you be at the #DrugDeliverySummit? 💊 DM Dan Dobry or David Vodak if you'd like to set up some time to meet. 💡 Let's talk about the next innovation in drug development. #PharmaCDMO #ContractManufacturing #DrugDevelopment #CDMOsolutions #InnovativeTherapeutics #AIinPharma Bend Bioscience + CoreRx, Inc.
To view or add a comment, sign in
-
📢 Exciting News! AmpleLogic is proud to be a Silver Sponsor at Federation of Asian Biotech Associations (FABA)! On August 7th at 11 AM, our very own Mr. Manne Venkanna Chowdary will take the virtual stage to discuss "Harnessing Digital Technologies for Enhanced Drug Manufacturing in Pharma." We're thrilled to be part of this insightful session! #AmpleLogic #FABA #DigitalTransformation #PharmaInnovation #IndustryLeadership
To view or add a comment, sign in
-
The multi-billion-dollar BioPharma industry is undergoing more change than ever before. The impending presidential election, ever escalating innovations in tech and AI, new drug legislation, and inflation all have an impact and it’s extremely challenging to predict the net effect. In our latest industry insight report, we investigate broader industry trends and also delve into talent insights for Massachusetts; the state that continues to be a beacon of innovation and growth. 👀 Sneak preview: from our research, Rapport Therapeutics, Ardelyx, Inc., Flagship Pioneering and Sumitomo Pharma America, Inc. were the fastest growing companies in their size bracket. Read the full report to find out who else featured, link in the comments ⬇
To view or add a comment, sign in
-
The first day of the NEXT Pharma Summit turned out to be quite an exhilarating one. Looking forward to more such interactions and discussions. Also, don't miss our session today @ 11:00 am CEST, Main Stage. Siddharth Malhotra Samir Faizi #Xcellen #technology #nextpharmasummit #pharmamarketing #commercialexcellence #pharma #dubrovnik
𝐇𝐞𝐥𝐥𝐨 𝐟𝐫𝐨𝐦 𝐃𝐮𝐛𝐫𝐨𝐯𝐧𝐢𝐤! Team Xcellen has touched down at the NEXT Pharma Summit, and the event is off to an electrifying start. If you are at the summit, don’t forget to swing by booth #18. We look forward to having some riveting conversations with you! Nikhil Gupta Siddharth Malhotra Aanchal Arora Richa Bhatli Vasu Gupta #Xcellen #technology #nextpharmasummit #pharmamarketing #commercialexcellence #pharma #digitaltransformation
To view or add a comment, sign in
-
Leading Business Model Transformation in Health. Physician, Executive, and Innovator in Digital Health.
"(...) Medicine Development and commercialization will be dominated by Data companies with Biotech and Pharma companies playing the role of a substrate supplier to algorithms" (Dr. Michael Zaiac) The writing is on the wall. If this happens, it will be a seismic shift affecting all aspects of healthcare. For many established players, this will pose a major threat to their business model. But within this threat, there is also opportunity. For patients, for Data companies - and for a few Pharma companies who get it right. Thanks Michael Zaiac for spelling it out and Bora Erdemli for posting! #futureofhealthcare #datadrivenmedicine #genAI
In one of the afternoon sessions at BioTechX Europe, Michael Zaiac talked about the role of #genAI in #medicalaffairs, where we are today and where we will be. And, he finished it with his future vision where the today’s pharma value chain from discovery to commercialization is dominated by “data companies” with biotech / pharma playing the role ofa substrate supplier.
To view or add a comment, sign in
-
Novelty for those of us pursuing new therapeutic agents within the specialized drug discovery domain extends far beyond what is merely new. It demands both innovation and practical applicability. Here's our take on the challenge of novelty in drug discovery. #drugdiscovery #biopharma #drugresearch #innovation #seeIPdifferently #biotech #drugresearch https://lnkd.in/etXdjbtZ
To view or add a comment, sign in
-
Attending events like Life Science Strategy Summit on IP & Exclusivity in München gives NLO a chance to meet our IP colleagues in Pharma and dive into the latest developments in Life Science strategy in Pharma and to discuss and share knowledge on how to contribute to the success of drug development programs of our customers. That’s why Mari Korsten and Kolja Adamczyk join the Life Science Summit in Munchen on 8 - 10 Oct 2024. . . . #IP #IntellectualProperty #pharma #lifescience #strategy
To view or add a comment, sign in
-
The opening session of our #OSP conference will dive into Physiologically Based Biopharmaceutics Modeling (#PBBM) with #PKSim — an increasingly explored approach in drug development. 💊 Speakers will provide insights into recent developments for #PBBM workflows for the #OSP Suite and industrial applications. 🤝 Join us as our expert speakers share insights and the newest advancements in this evolving field. Our expert speakers for Session I are: Mariana Guimarães, Paul Vrenken and Fabian Winter. 👀 Check the full program here: https://lnkd.in/e8ByamUg #PBPK #PBBM #PKSim #MoBi #OSPCommunity #pharma #conference #lifesciences #innovation #community
To view or add a comment, sign in
-
Axsendo Clinical Research is gearing up for #DIA2024 - We're eager to connect with industry leaders to discuss innovative clinical research solutions, like ours! Reach out to schedule a meeting and explore how we can enhance the quality, efficiency, and diversity of your clinical trial projects. See you there! #BioPharma #BioTech #LifeSciences #ClinicalResearch
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Vanqua raises $45M; Aerovate to look for strategic alternatives >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #healthcare #pharma
To view or add a comment, sign in
4,483 followers